Clinical trial
An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients.
NCT00792571 is registered in ClinicalTrials.gov with Lung Biotechnology PBC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients.
- Lead sponsor
- Lung Biotechnology PBC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- November 30, 2013
- Enrollment
- 18 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.